Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients

References

• ScottDLWolfeFHuizingaTWJRheumatoid arthritisLancet201037697461094110820870100
   PubMed Web of Science ®Google Scholar
• HumphreysJHVerstappenSMMHyrichKLChippingJRMarshallTSymmonsDPMThe incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis RegisterAnn Rheum Dis20137281315132022945499
   PubMed Web of Science ®Google Scholar
• KapetanovicMCLindqvistENilssonJ-AGeborekPSaxneTEberhardtKDevelopment of functional impairment and disability in rheumatoid arthritis patients followed for 20 years: relation to disease activity, joint damage, and comorbidityArthritis Care Res (Hoboken)201567334034825186552
   PubMed Web of Science ®Google Scholar
• ElliottRAShinogleJAPeelePBhosleMHughesDAUnderstanding medication compliance and persistence from an economics perspectiveValue Health200811460061018194403
   PubMed Web of Science ®Google Scholar
• SmolenJSLandewéRBreedveldFCEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnn Rheum Dis201473349250924161836
   PubMed Web of Science ®Google Scholar
• SaltEFrazierSKAdherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritisOrthop Nurs201029426027520664466
   PubMed Web of Science ®Google Scholar
• RadnerHYoshidaKHmamouchiIDougadosMSmolenJSSolomonDHTreatment patterns of multimorbid patients with rheumatoid arthritis: results from an international cross-sectional studyJ Rheumatol20154271099110426034147
   PubMed Web of Science ®Google Scholar
• Lopez-GonzalezRLeonLLozaERedondoMGarcia de YebenesMJCarmonaLAdherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature reviewClin Exp Rheumatol201533455956925602291
   PubMed Web of Science ®Google Scholar
• EmeryPTreatment of rheumatoid arthritisBMJ2006332753415215516424492
   PubMed Web of Science ®Google Scholar
• SmolenJSAletahaDBijlsmaJWJTreating rheumatoid arthritis to target: recommendations of an international task forceAnn Rheum Dis201069463163720215140
   PubMed Web of Science ®Google Scholar
• BlumMAKooDDoshiJAMeasurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic reviewClin Ther201133790191321715007
   PubMed Web of Science ®Google Scholar
• Federal Data Protection Act. Federal Data Protection Act in the version promulgated on 14 January 2003 (Federal Law Gazette I p. 66), as most recently amended by Article 1 of the Act of 14 August 2009 (Federal Law Gazette I p. 2814) Available from: https://www.gesetzeim-internet.de/englisch_bdsg/englisch_bdsg.pdfAccessed May 25, 2017
   Google Scholar
• Working Group for the Survey and Utilization of Secondary Data (AGENS); Working Group for Epidemiological MethodsGPS – Good Practice in Secondary Data Analysis: Revision after Fundamental Reworking2008 Available from: http://dgepi.de/fileadmin/pdf/leitlinien/gps-version2-final_ENG.pdfAccessed May 25, 2017
   Google Scholar
• Bundesverband der Pharmazeutischen Industrie e.V., Institut für Pharmakoökonomie und Arzneimittellogistik e.VLeitfaden zur Planung von Versorgungsforschungsstudien in pharmazeutischen UnternehmenBerlin2015
   Google Scholar
• PasmaAvan’t SpijkerAHazesJMWBusschbachJJVLuimeJJFactors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic reviewSemin Arthritis Rheum2013431182823352247
   PubMed Web of Science ®Google Scholar
• ZeberJEManiasEWilliamsAFA systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest groupValue Health201316589190023947984
   PubMed Web of Science ®Google Scholar
• WilkeTMullerSMoriskyDEToward identifying the causes and combinations of causes increasing the risks of nonadherence to medical regimens: combined results of two German self-report surveysValue Health20111481092110022152179
   PubMed Web of Science ®Google Scholar
• KatchamartWTrudeauJPhumethumVBombardierCMethotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritisCochrane Database Syst Rev20104CD008495
   Google Scholar
• GrigorCCapellHStirlingAEffect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trialLancet2004364943026326915262104
   PubMed Web of Science ®Google Scholar
• GrijalvaCGKaltenbachLArbogastPGMitchelEFGriffinMRAdherence to disease-modifying antirheumatic drugs and the effects of exposure misclassification on the risk of hospital admissionArthritis Care Res2010625730734
   Web of Science ®Google Scholar
• HarleyCRFrytakJRTandonNTreatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexateAm J Manag Care200396 supplS136S14314577718
   PubMed Web of Science ®Google Scholar
• CannonGWMikulsTRHaydenCLMerging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practiceArthritis Care Res (Hoboken)201163121680169021905260
   PubMed Web of Science ®Google Scholar
• TangBRahmanMWatersHCCallegariPTreatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritisClin Ther20083071375138418691998
   PubMed Web of Science ®Google Scholar
• BliddalHEriksenSAChristensenRAdherence to methotrexate in rheumatoid arthritis: a Danish nationwide cohort studyArthritis2015201591514225810923
   PubMedGoogle Scholar
• BelinchonIRiveraRBlanchCComellasMLizanLAdherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literaturePatient Prefer Adherence2016102357236727895471
   PubMed Web of Science ®Google Scholar
• PolonskyWHHenryRRPoor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsPatient Prefer Adherence2016101299130727524885
   PubMed Web of Science ®Google Scholar
• MoonZMoss-MorrisRHunterMSCarlisleSHughesLDBarriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic reviewPatient Prefer Adherence20171130532228260867
   PubMed Web of Science ®Google Scholar
• TestaACastiglioneFNardoneOMColomboGLAdherence in ulcerative colitis: an overviewPatient Prefer Adherence20171129730328260866
   PubMed Web of Science ®Google Scholar
• WilkeTGrothAMuellerSHow to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitusEur J Health Econ201314355156822815097
   PubMed Web of Science ®Google Scholar